Amipaque myelography. The side effects compared with Dimer X.
In a comparative study between Dimer X and Amipaque (metrizamide) for lumbar myelography it was found that there is a little higher frequency of monor, but unimportant side effects after Amipaque. Amipaque has also been used for thoracocervical myelography with excellent results and without greater discomfort than after myelography in the lumbar region. A new puncture technique was used for the eximation of the cervical region alone: lateral puncture on the neck between the laminae of C1 and C2 under TV control. In more than 75 reinvestigations no arachnoid changes were observed.
D000328:Adult; D000368:Aged; D005260:Female; D005334:Fever / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007463:Iodobenzoates / Q000009:adverse effects*; D007482:Iothalamate Meglumine / Q000009:adverse effects*; D007483:Iothalamic Acid / Q000031:analogs & derivatives*; D008161:Lumbosacral Region; D008297:Male; D008793:Metrizamide / Q000009:adverse effects*; D008875:Middle Aged; D009192:Myelography / Q000009:adverse effects* / Q000379:methods; D009325:Nausea / Q000139:chemically induced; D009333:Neck; D012640:Seizures / Q000139:chemically induced; D013346:Subarachnoid Space / Q000000981:diagnostic imaging; D011795:Surveys and Questionnaires; D014555:Urination Disorders / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D007463:Iodobenzoates; D007483:Iothalamic Acid; D008793:Metrizamide; D007482:Iothalamate Meglumine